BioAdaptives Inc (BDPT)
BioAdaptives, Inc. is a Las Vegas, Nevada-based company incorporated in 2013 and listed on OTC Markets under the ticker BDPT. Through its common stock, investors gain exposure to a company that investigates, markets, and distributes natural products derived from plants, algae, and mushrooms for human and animal use. Its product and development focus includes nutraceuticals and dietary supplements, as well as items such as Human Clinical trial, Zeranovia, Lung Flute, Xcellara, PawPa, and MyndMed. The company was previously named APEX 8 Inc. before adopting the BioAdaptives name in September 2013.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BDPT
|
$0.0016
|
-30.4% Downside
|
Overvalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 13, 2026
|
15.4x
|
452.931 K
|
887.495 K
|
57.0%
|
-254.6
|
37.5%
|
